World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
16344
World Ranking
2428
National Ranking
93

Hirokazu Kanegane publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Hirokazu Kanegane sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 433 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Hirokazu Kanegane D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Hirokazu Kanegane sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Hirokazu Kanegane is affiliated with Tokyo Medical and Dental University in Japan and conducts research primarily in the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Their work focuses on several subfields including Immunology, Genetics, Hematology, Epidemiology, and Infectious Diseases.

Their research addresses topics related to Immunodeficiency and Autoimmune Disorders, Autoimmune and Inflammatory Disorders Research, Immune Cell Function and Interaction, Blood Disorders and Treatments, Chronic Lymphocytic Leukemia Research, Parvovirus B19 Infection Studies, and Cytomegalovirus and Herpesvirus Research.

Kanegane has contributed to multiple recent papers, including:

  • Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency, 2021, Science Immunology
  • A variant in human AIOLOS impairs adaptive immunity by interfering with IKAROS, 2021, Nature Immunology
  • APRIL-dependent lifelong plasmacyte maintenance and immunoglobulin production in humans, 2020, Journal of Allergy and Clinical Immunology
  • Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation, 2021, Journal of Allergy and Clinical Immunology
  • Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19, 2022, Journal of Clinical Immunology

The scientist's frequent coauthors include:

  • Tomohiro Morio (67 coauthored works)
  • Kohsuke Imai (48 coauthored works)
  • Dan Tomomasa (35 coauthored works)
  • Masatoshi Takagi (34 coauthored works)
  • Satoshi Okada (33 coauthored works)

Kanegane's publications often appear in journals such as:

  • Journal of Clinical Immunology (34 publications)
  • Frontiers in Immunology (21 publications)
  • Pediatrics International (14 publications)
  • International Journal of Hematology (10 publications)
  • Clinical Immunology (6 publications)

Best Publications

  • Clinical and virologic characteristics of chronic active Epstein-Barr virus infection

    Hiroshi Kimura;Yo Hoshino;Hirokazu Kanegane;Ikuya Tsuge

  • Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects

    Charlotte Schwab;Annemarie Gabrysch;Peter Olbrich;Virginia Patiño

  • The landscape of somatic mutations in Down syndrome-related myeloid disorders

    Kenichi Yoshida;Tsutomu Toki;Yusuke Okuno;Rika Kanezaki

  • Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP-deficiency) versus type 2 (XLP-2/XIAP-deficiency)

    Jana Pachlopnik Schmid;Jana Pachlopnik Schmid;Danielle Canioni;Despina Moshous;Despina Moshous;Fabien Touzot

  • Proposed guidelines for diagnosing chronic active epstein-barr virus infection

    Motohiko Okano;Keisei Kawa;Hiroshi Kimura;Akihiro Yachie

  • X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management, and outcome of the disease

    Claire Booth;Kimberly C. Gilmour;Paul Veys;Andrew R. Gennery

  • Prognostic Factors for Chronic Active Epstein-Barr Virus Infection

    Hiroshi Kimura;Tsuneo Morishima;Hirokazu Kanegane;Shouichi Ohga

  • Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study

    Federica Barzaghi;Laura Cristina Amaya Hernandez;Benedicte Neven;Silvia Ricci

  • XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation

    Monica Yabal;Nicole Müller;Heiko Adler;Nathalie Knies

  • Genetic analysis of patients with defects in early B-cell development

    Mary Ellen Conley;Mary Ellen Conley;Arnon Broides;Arnon Broides;Vivian Hernandez-Trujillo;Vanessa Howard

  • The Role of Mig, the Monokine Induced by Interferon-γ, and IP-10, the Interferon-γ–Inducible Protein-10, in Tissue Necrosis and Vascular Damage Associated With Epstein-Barr Virus-Positive Lymphoproliferative Disease

    Julie Teruya-Feldstein;Elaine S. Jaffe;Parris R. Burd;Hirokazu Kanegane

  • Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12.

    Priti T. Mehrotra;Raymond P. Donnelly;Susan Wong;Hirokazu Kanegane

  • Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12.

    Chiharu Kanegane;Cecilia Sgadari;Hirokazu Kanegane;Julie Teruya-Feldstein

  • Interleukin-15 Promotes Angiogenesisin Vivo

    Anne L. Angiolillo;Hirokazu Kanegane;Cecilia Sgadari;Gregory H. Reaman

  • Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency

    David Boutboul;Hye Sun Kuehn;Zoé Van de Wyngaert;Zoé Van de Wyngaert;Julie E. Niemela

  • Chemokine receptor expression and functional effects of chemokines on B cells: implication in the pathogenesis of rheumatoid arthritis

    Toshihiro Nanki;Kazuki Takada;Yukiko Komano;Tomohiro Morio

  • Novel mutations in a Japanese patient with CD19 deficiency

    H Kanegane;K Agematsu;T Futatani;M M Sira

  • Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency.

    Taizo Wada;Hirokazu Kanegane;Kazuhide Ohta;Fumiyo Katoh

  • Role of transforming growth factor-β in breast milk for initiation of IgA production in newborn infants

    Jiro Ogawa;Akiko Sasahara;Taketoshi Yoshida;Mostafa Mohamed Sira

  • Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes

    Rebecca A. Marsh;Kanchan Rao;Prakash Satwani;Kai Lehmberg

  • Primary immunodeficiency diseases

    Takeshi Futatani;Hirokazu Kanegane;Toshio Miyawaki

Frequent Co-Authors

Toshio Miyawaki
Toshio Miyawaki University of Toyama
Kohsuke Imai
Kohsuke Imai Tokyo Medical and Dental University
Tomohiro Morio
Tomohiro Morio Institute of Science Tokyo
Shigeaki Nonoyama
Shigeaki Nonoyama National Defense Medical College
Seiji Kojima
Seiji Kojima Nagoya University
Osamu Ohara
Osamu Ohara Chiba University
Seishi Ogawa
Seishi Ogawa Kyoto University
Akihiro Yachie
Akihiro Yachie Kanazawa University
Satoru Miyano
Satoru Miyano Tokyo Medical and Dental University
Etsuro Ito
Etsuro Ito Hirosaki University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, expanding your qualifications through related healthcare degrees can open multiple career pathways. Many students choose to complement their scientific background with nursing programs that emphasize patient care and clinical skills.

Accelerated options make it possible to quickly transition into advanced practice roles. For example, exploring accelerated FNP programs allows graduates to become Family Nurse Practitioners and provide primary care services in various healthcare settings.

If you are new to nursing and wondering how to enter the field fast, online accelerated nursing programs for non nurses offer a streamlined path to obtain a registered nursing license.

Additionally, those seeking a quicker route may consider the easiest ABSN programs to get into, which focus on accelerated Bachelor of Science in Nursing degrees designed for career changers.

For entry-level roles in nursing, researching which LPN programs are easiest to get into can help you find accessible Licensed Practical Nurse programs that fit your goals and timeline.

Overall, pursuing related online degrees not only broadens your expertise but also enhances employment opportunities in healthcare fields connected to immunology.

Best Scientists Citing Hirokazu Kanegane

Trending Scientists

Recently Published Articles